KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Unitedhealth (UNH) Cash from Financing Activities (2016 - 2025)

Unitedhealth (UNH) has disclosed Cash from Financing Activities for 17 consecutive years, with -$1.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 87.64% to -$1.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$11.6 billion, a 231.55% decrease, with the full-year FY2025 number at -$11.6 billion, down 231.55% from a year prior.
  • Cash from Financing Activities was -$1.0 billion for Q4 2025 at Unitedhealth, up from -$2.8 billion in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $13.2 billion in Q1 2023 to a low of -$10.5 billion in Q2 2023.
  • A 5-year average of -$1.5 billion and a median of -$1.7 billion in 2024 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: surged 533.94% in 2022, then crashed 1205.6% in 2023.
  • Unitedhealth's Cash from Financing Activities stood at -$3.6 billion in 2021, then surged by 221.09% to $4.4 billion in 2022, then plummeted by 262.93% to -$7.2 billion in 2023, then fell by 16.57% to -$8.3 billion in 2024, then skyrocketed by 87.64% to -$1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for UNH's Cash from Financing Activities are -$1.0 billion (Q4 2025), -$2.8 billion (Q3 2025), and -$7.9 billion (Q2 2025).